ALVR logo Allovir Inc : ALVR

ALVR

Stock Data

$9.78

Change down

$0.01 (0.10%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Allovir, Inc., a clinical-stage cell therapy company, is dedicated to the research and development of ready-to-use, multi-virus-specific allogeneic T-cell therapies (TSVs) to prevent and treat devastating virus-associated diseases. The company is headquartered in Cambridge, Massachusetts.

All ALVR Articles

11 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.